Dr. Qin Lunxiu (钦伦秀) - Director of Hematology at Ruijin Hospital

Dr. Qin Lunxiu (钦伦秀) - Director of Hematology at Ruijin Hospital

Introduction

Dr. Qin Lunxiu (钦伦秀) is a leading hematologist at Shanghai Jiao Tong University School of Medicine's Ruijin Hospital, one of China's premier centers for blood disorders and hematologic malignancies. With over 25 years of specialized experience in treating leukemia, lymphoma, and other blood diseases, Dr. Qin is recognized as an expert in acute leukemia treatment, hematopoietic stem cell transplantation, and targeted therapy for hematologic cancers. His expertise in managing complex blood disorders, combined with Ruijin Hospital's world-class hematology resources, makes him a top choice for international patients seeking advanced hematology care in Shanghai.

Academic Distinctions & Leadership

  • Chief Physician, Department of Hematology, Ruijin Hospital
  • Professor of Hematology, Shanghai Jiao Tong University School of Medicine
  • Standing Committee Member, Chinese Society of Hematology
  • Member, American Society of Hematology (ASH)
  • Member, European Hematology Association (EHA)
  • Editorial Board Member, Chinese Journal of Hematology
  • Trained at leading hematology centers internationally
  • Recipient, Shanghai Medical Science and Technology Award

Specializations & Expertise

Acute Leukemia

  • Acute myeloid leukemia (AML) treatment
  • Acute lymphoblastic leukemia (ALL) treatment
  • Acute promyelocytic leukemia (APL)
  • Relapsed and refractory acute leukemia
  • Minimal residual disease (MRD) monitoring
  • Targeted therapy for leukemia
  • Chemotherapy protocols

Chronic Leukemia

  • Chronic myeloid leukemia (CML) with tyrosine kinase inhibitors
  • Chronic lymphocytic leukemia (CLL)
  • Hairy cell leukemia

Lymphoma

  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma (diffuse large B-cell, follicular, mantle cell, etc.)
  • T-cell lymphomas
  • Relapsed and refractory lymphoma
  • CAR-T cell therapy for lymphoma

Multiple Myeloma

  • Newly diagnosed myeloma treatment
  • Relapsed/refractory myeloma
  • Novel agent therapy (proteasome inhibitors, immunomodulatory drugs)
  • Autologous stem cell transplantation

Hematopoietic Stem Cell Transplantation

  • Allogeneic stem cell transplantation
  • Autologous stem cell transplantation
  • Haploidentical transplantation
  • Graft-versus-host disease (GVHD) management
  • Post-transplant complications

Other Blood Disorders

  • Aplastic anemia
  • Myelodysplastic syndromes (MDS)
  • Myeloproliferative neoplasms
  • Hemolytic anemias
  • Immune thrombocytopenia (ITP)

Clinical Excellence & Innovation

Dr. Qin has treated thousands of patients with hematologic malignancies and blood disorders throughout his career. His expertise in acute leukemia treatment has achieved remission rates that meet or exceed international benchmarks, with particular success in acute promyelocytic leukemia (APL) where cure rates exceed 90%.

Dr. Qin utilizes the latest advances in hematology including:

  • Targeted therapy based on molecular profiling
  • Minimal residual disease monitoring to guide treatment
  • Novel immunotherapies including CAR-T cell therapy
  • Risk-adapted treatment strategies
  • Supportive care optimization to reduce treatment toxicity

Research & Academic Contributions

Dr. Qin has published extensively in Chinese and international hematology journals. His research focuses on improving outcomes in acute leukemia, optimizing stem cell transplantation, and developing novel treatment strategies for hematologic malignancies.

Hospital Affiliation

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
197 Ruijin Er Road, Huangpu District, Shanghai 200025

Ruijin Hospital's Department of Hematology is one of China's premier hematology centers, featuring:

  • Comprehensive hematology inpatient and outpatient services
  • Bone marrow transplantation unit
  • Advanced flow cytometry and molecular diagnostics
  • CAR-T cell therapy program
  • Clinical trials for novel therapies
  • Supportive care services
  • International patient services

Patient Care Philosophy

  • Personalized Treatment: Tailored therapy based on disease characteristics and patient factors
  • Evidence-Based Care: Treatment guided by latest research and international guidelines
  • Multidisciplinary Approach: Collaboration with transplant teams, pathologists, and other specialists
  • Comprehensive Support: Addressing medical, emotional, and practical needs
  • Transparent Communication: Clear discussion of diagnosis, prognosis, and treatment options

Why Choose Dr. Qin Lunxiu?

  • Extensive Experience: Over 25 years treating hematologic malignancies
  • Excellent Outcomes: Remission and survival rates meeting international standards
  • Advanced Therapies: Access to latest treatments including targeted therapy and CAR-T
  • World-Class Facility: Ruijin Hospital's exceptional hematology resources
  • Cost-Effective Care: Treatment costs 60-75% lower than US or Europe
  • International Experience: Trusted by patients from many countries

Conditions Treated

Leukemias

  • Acute myeloid leukemia (AML)
  • Acute lymphoblastic leukemia (ALL)
  • Acute promyelocytic leukemia (APL)
  • Chronic myeloid leukemia (CML)
  • Chronic lymphocytic leukemia (CLL)

Lymphomas

  • Hodgkin lymphoma
  • Diffuse large B-cell lymphoma
  • Follicular lymphoma
  • Mantle cell lymphoma
  • T-cell lymphomas

Plasma Cell Disorders

  • Multiple myeloma
  • Waldenstrom macroglobulinemia
  • Amyloidosis

Other Blood Disorders

  • Myelodysplastic syndromes
  • Aplastic anemia
  • Myeloproliferative neoplasms

International Patient Services

China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking hematology care with Dr. Qin at Ruijin Hospital.

Pre-Arrival Support

  • Medical record and pathology review
  • Virtual consultation arrangement
  • Treatment planning
  • Cost transparency
  • Visa and travel assistance

During Treatment

  • Professional medical interpretation
  • Hospital navigation support
  • Coordination of testing and procedures
  • Medication procurement assistance
  • 24/7 support

Post-Treatment Care

  • Report translation
  • Follow-up coordination
  • Medication guidance
  • Telemedicine support
  • Long-term assistance

Schedule Your Consultation

If you or a loved one has been diagnosed with leukemia, lymphoma, or another blood disorder, Dr. Qin Lunxiu at Ruijin Hospital offers expert hematology care with access to the latest treatments.

Contact China Medical Concierge - Shanghai today to begin your journey to expert hematology care in Shanghai.

Bridging international patients with Shanghai's finest hematologists - because every blood cancer patient deserves expert care.

0 Kommentare

Hinterlasse einen Kommentar